Lyra Therapeutics Announces Appointment of John Bishop, Ph.D., as Chief Technology Officer
Stock Information for Lyra Therapeutics Inc.
Please wait while we load your information from QuoteMedia.
More Recent News About Lyra Therapeutics Inc.
Lyra Therapeutics Announces Restart of Pivotal Phase 3 ENLIGHTEN II Clinical Trial of LYR-210 in Chronic Rhinosinusitis